JP2025512777A5 - - Google Patents
Info
- Publication number
- JP2025512777A5 JP2025512777A5 JP2024556112A JP2024556112A JP2025512777A5 JP 2025512777 A5 JP2025512777 A5 JP 2025512777A5 JP 2024556112 A JP2024556112 A JP 2024556112A JP 2024556112 A JP2024556112 A JP 2024556112A JP 2025512777 A5 JP2025512777 A5 JP 2025512777A5
- Authority
- JP
- Japan
- Prior art keywords
- unsubstituted
- substituted
- formula
- pharmaceutically acceptable
- hydrogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263323421P | 2022-03-24 | 2022-03-24 | |
| US63/323,421 | 2022-03-24 | ||
| PCT/US2023/015914 WO2023183394A1 (en) | 2022-03-24 | 2023-03-22 | Alpha 1a-adrenergic receptor agonists and methods of use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025512777A JP2025512777A (ja) | 2025-04-22 |
| JP2025512777A5 true JP2025512777A5 (cg-RX-API-DMAC7.html) | 2026-03-18 |
Family
ID=88101941
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024556112A Pending JP2025512777A (ja) | 2022-03-24 | 2023-03-22 | アルファ１ａ－アドレナリン受容体アゴニスト及びその使用方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20250188060A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4499070A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2025512777A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240165433A (cg-RX-API-DMAC7.html) |
| CN (1) | CN119013020A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2023240170A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3245920A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL315798A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2024011674A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023183394A1 (cg-RX-API-DMAC7.html) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2337909C2 (ru) * | 2002-02-01 | 2008-11-10 | Ф.Хоффманн-Ля Рош Аг | Замещенные индолы и фармацевтическая композиция, обладающая агонистической активностью в отношении альфа-1a/l адренорецептора |
| CA2637312A1 (en) * | 2006-01-27 | 2007-08-02 | F. Hoffmann-La Roche Ag | Use of substituted 2-imidazole of imidazoline derivatives |
| DK3421471T3 (da) * | 2006-04-25 | 2021-06-14 | Astex Therapeutics Ltd | Purin- og deazapurinderivater som farmaceutiske forbindelser |
-
2023
- 2023-03-22 CN CN202380029402.1A patent/CN119013020A/zh active Pending
- 2023-03-22 JP JP2024556112A patent/JP2025512777A/ja active Pending
- 2023-03-22 KR KR1020247035218A patent/KR20240165433A/ko active Pending
- 2023-03-22 EP EP23775602.8A patent/EP4499070A1/en active Pending
- 2023-03-22 CA CA3245920A patent/CA3245920A1/en active Pending
- 2023-03-22 US US18/847,147 patent/US20250188060A1/en active Pending
- 2023-03-22 MX MX2024011674A patent/MX2024011674A/es unknown
- 2023-03-22 AU AU2023240170A patent/AU2023240170A1/en active Pending
- 2023-03-22 IL IL315798A patent/IL315798A/en unknown
- 2023-03-22 WO PCT/US2023/015914 patent/WO2023183394A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022527769A5 (cg-RX-API-DMAC7.html) | ||
| EA005520B1 (ru) | Карбаматы, полученные из арилалкиламинов | |
| HRP20010585A2 (en) | Monoamine reuptake inhibitors for treatment of cns disorders | |
| BRPI0308696B8 (pt) | composto derivado de quinolina, seu processo de preparação, sua composição farmacêutica e seus usos | |
| PT2816024T (pt) | Aminas quirais | |
| CA2688493A1 (en) | Phenyl substituted cycloalkylamines as monoamine reuptake inhibitors | |
| ME01480B (me) | DERIVATI 5-AMIN0-2,4,7-TRIOKS0-3,4,7,8-TETRAHIDR0-2H-PIRID0[2,3-d]PIRIMIDINA I SRODNI SPOJEVI, NAMIJENJENI LIJEČENJU RAKA | |
| BRPI0612803A2 (pt) | processo para preparar um composto | |
| RU2005104434A (ru) | Производные 1-гетероциклилалкил-3-сульфонилиндола или - индазола как лиганды 5-гидрокситриптамина-6 | |
| JP2023528450A5 (cg-RX-API-DMAC7.html) | ||
| EP2455075B1 (en) | Process for Preparation of trans 4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine | |
| US10913711B2 (en) | Potent and selective inhibitors of monoamine transporters; method of making; and use thereof | |
| JP2021527711A5 (cg-RX-API-DMAC7.html) | ||
| JP6687596B2 (ja) | Ｎ−［４−（１−アミノエチル）−フェニル］−スルホンアミド誘導体のキラル分割方法 | |
| JP2011529069A5 (cg-RX-API-DMAC7.html) | ||
| JP2010509334A5 (cg-RX-API-DMAC7.html) | ||
| JP2025512777A5 (cg-RX-API-DMAC7.html) | ||
| JP2023541375A5 (cg-RX-API-DMAC7.html) | ||
| TWI725098B (zh) | 藉由使用極性非質子性溶劑掌性解析n-[4-(1-胺基乙基)-苯基]-磺醯胺衍生物之方法 | |
| JP2014520785A5 (cg-RX-API-DMAC7.html) | ||
| RU2014104372A (ru) | Позитивные аллостерические модуляторы никотинового рецептора ацетилхолина | |
| JP2023552292A5 (cg-RX-API-DMAC7.html) | ||
| RU2013158817A (ru) | Способ синтеза и кристаллическая форма гидрохлорида 4-{3-[цис-гексагидроциклопента[c]пиррол-2(1н)-ил]пропокси}бензамида и содержащие ее фармацевтические композиции | |
| JP2024536815A5 (cg-RX-API-DMAC7.html) | ||
| HU187789B (en) | Process for preparing 2-amino-1,2,3,4-tetrahydro-naphtalena derivatives |